vs
Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and MMTec, Inc. (MTC). Click either name above to swap in a different company.
Insight Molecular Diagnostics Inc. is the larger business by last-quarter revenue ($1.1M vs $807.5K, roughly 1.4× MMTec, Inc.). Insight Molecular Diagnostics Inc. runs the higher net margin — -2015.4% vs -5749.7%, a 3734.3% gap on every dollar of revenue.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
MMTec, Inc. is a global fintech enterprise that develops and delivers integrated trading technology solutions, including high-performance trading platforms, real-time market data services, and risk management systems. Its core clients cover brokerage firms, asset management institutions, and professional traders across North America and the Asia-Pacific region, helping financial market participants boost trading efficiency and operational security.
IMDX vs MTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1M | $807.5K |
| Net Profit | $-23.0M | $-46.4M |
| Gross Margin | 42.5% | 83.5% |
| Operating Margin | -2057.5% | -189.7% |
| Net Margin | -2015.4% | -5749.7% |
| Revenue YoY | -23.4% | — |
| Net Profit YoY | 31.5% | — |
| EPS (diluted) | $-0.75 | $-1.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1M | — | ||
| Q3 25 | $260.0K | — | ||
| Q2 25 | $518.0K | $807.5K | ||
| Q1 25 | $2.1M | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $115.0K | — | ||
| Q2 24 | $104.0K | — | ||
| Q1 24 | $176.0K | — |
| Q4 25 | $-23.0M | — | ||
| Q3 25 | $-10.9M | — | ||
| Q2 25 | $-9.7M | $-46.4M | ||
| Q1 25 | $-6.7M | — | ||
| Q4 24 | $-33.5M | — | ||
| Q3 24 | $-13.5M | — | ||
| Q2 24 | $-4.5M | — | ||
| Q1 24 | $-9.1M | — |
| Q4 25 | 42.5% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 67.6% | 83.5% | ||
| Q1 25 | 62.0% | — | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 43.5% | — | ||
| Q2 24 | 48.1% | — | ||
| Q1 24 | 25.6% | — |
| Q4 25 | -2057.5% | — | ||
| Q3 25 | -4249.2% | — | ||
| Q2 25 | -1900.0% | -189.7% | ||
| Q1 25 | -318.0% | — | ||
| Q4 24 | -2262.9% | — | ||
| Q3 24 | -11752.2% | — | ||
| Q2 24 | -4453.8% | — | ||
| Q1 24 | -5265.3% | — |
| Q4 25 | -2015.4% | — | ||
| Q3 25 | -4174.6% | — | ||
| Q2 25 | -1880.7% | -5749.7% | ||
| Q1 25 | -312.0% | — | ||
| Q4 24 | -2255.1% | — | ||
| Q3 24 | -11733.0% | — | ||
| Q2 24 | -4355.8% | — | ||
| Q1 24 | -5186.9% | — |
| Q4 25 | $-0.75 | — | ||
| Q3 25 | $-0.34 | — | ||
| Q2 25 | $-0.30 | $-1.84 | ||
| Q1 25 | $-0.26 | — | ||
| Q4 24 | $-2.19 | — | ||
| Q3 24 | $-0.98 | — | ||
| Q2 24 | $-0.36 | — | ||
| Q1 24 | $-1.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $10.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-31.5M | $-19.8M |
| Total Assets | $25.8M | $20.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | — | ||
| Q3 25 | $18.7M | — | ||
| Q2 25 | $24.3M | $10.2M | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $5.6M | — |
| Q4 25 | $-31.5M | — | ||
| Q3 25 | $-9.2M | — | ||
| Q2 25 | $1.1M | $-19.8M | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | $-12.3M | — | ||
| Q3 24 | $9.7M | — | ||
| Q2 24 | $22.7M | — | ||
| Q1 24 | $11.6M | — |
| Q4 25 | $25.8M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | $50.5M | $20.3M | ||
| Q1 25 | $60.4M | — | ||
| Q4 24 | $35.1M | — | ||
| Q3 24 | $70.2M | — | ||
| Q2 24 | $74.7M | — | ||
| Q1 24 | $71.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-1.7M |
| Free Cash FlowOCF − Capex | $-7.0M | — |
| FCF MarginFCF / Revenue | -616.7% | — |
| Capex IntensityCapex / Revenue | 129.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $-4.5M | — | ||
| Q2 25 | $-6.3M | $-1.7M | ||
| Q1 25 | $-5.9M | — | ||
| Q4 24 | $-5.4M | — | ||
| Q3 24 | $-5.5M | — | ||
| Q2 24 | $-6.0M | — | ||
| Q1 24 | $-3.8M | — |
| Q4 25 | $-7.0M | — | ||
| Q3 25 | $-5.6M | — | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | $-5.6M | — | ||
| Q3 24 | $-5.6M | — | ||
| Q2 24 | $-6.2M | — | ||
| Q1 24 | $-3.9M | — |
| Q4 25 | -616.7% | — | ||
| Q3 25 | -2135.4% | — | ||
| Q2 25 | -1279.5% | — | ||
| Q1 25 | -288.4% | — | ||
| Q4 24 | -374.5% | — | ||
| Q3 24 | -4884.3% | — | ||
| Q2 24 | -5931.7% | — | ||
| Q1 24 | -2189.8% | — |
| Q4 25 | 129.9% | — | ||
| Q3 25 | 403.8% | — | ||
| Q2 25 | 67.4% | — | ||
| Q1 25 | 14.4% | — | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 75.7% | — | ||
| Q2 24 | 183.7% | — | ||
| Q1 24 | 13.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
